These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 32587099

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
    Bournique B, Lambert N, Boukaiba R, Martinet M.
    Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol.
    Alves P, Amaral C, Teixeira N, Correia-da-Silva G.
    Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
    [Abstract] [Full Text] [Related]

  • 48. Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study.
    Varadi G, Zhu Z, Crowley HD, Moulin M, Dey R, Lewis ED, Evans M.
    Adv Ther; 2023 Jan; 40(1):282-293. PubMed ID: 36308640
    [Abstract] [Full Text] [Related]

  • 49. Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders.
    Fernández-Trapero M, Pérez-Díaz C, Espejo-Porras F, de Lago E, Fernández-Ruiz J.
    Biomolecules; 2020 Feb 11; 10(2):. PubMed ID: 32054131
    [Abstract] [Full Text] [Related]

  • 50. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kong TY, Kwon SS, Cheong JC, Kim HS, Kim JY, Lee HS.
    Molecules; 2018 Apr 16; 23(4):. PubMed ID: 29659506
    [Abstract] [Full Text] [Related]

  • 51. In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes.
    Zhang N, Liu J, Chen Z, Dou W.
    Pharm Biol; 2019 Dec 16; 57(1):571-576. PubMed ID: 31456483
    [Abstract] [Full Text] [Related]

  • 52. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H, Ahad A, Mostafa GAE, Al-Jenoobi FI.
    Eur J Drug Metab Pharmacokinet; 2018 Dec 16; 43(6):707-713. PubMed ID: 29744741
    [Abstract] [Full Text] [Related]

  • 53. Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9-tetrahydrocannabinol: a pilot study.
    Peters EN, MacNair L, Mosesova I, Christians U, Sempio C, Klawitter J, Land MH, Ware MA, Turcotte C, Bonn-Miller MO.
    Eur J Clin Pharmacol; 2022 Feb 16; 78(2):259-265. PubMed ID: 34664109
    [Abstract] [Full Text] [Related]

  • 54. Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.
    Zhang H, Ya G, Rui H.
    Eur J Drug Metab Pharmacokinet; 2017 Feb 16; 42(1):89-98. PubMed ID: 26874845
    [Abstract] [Full Text] [Related]

  • 55. Assessment of drug-drug interaction for silymarin.
    Doehmer J, Tewes B, Klein KU, Gritzko K, Muschick H, Mengs U.
    Toxicol In Vitro; 2008 Apr 16; 22(3):610-7. PubMed ID: 18249085
    [Abstract] [Full Text] [Related]

  • 56. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization.
    Doohan PT, Oldfield LD, Arnold JC, Anderson LL.
    AAPS J; 2021 Jun 28; 23(4):91. PubMed ID: 34181150
    [Abstract] [Full Text] [Related]

  • 57. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
    Lin PP, Li XN, Yuan F, Chen WL, Yang MJ, Xu HR.
    Biochem Biophys Res Commun; 2016 Nov 11; 480(2):248-253. PubMed ID: 27751854
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S, Fujimaki Y, Yokoyama H, Okazaki O, Sudo K.
    Drug Metab Dispos; 2005 Nov 11; 33(11):1628-36. PubMed ID: 16049129
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.